K982027

Substantially Equivalent

MODIFICATION TO COPALIS CMV TOTAL ANTIBODY ASSAY

Applicant: DiaSorin, Inc.
Product code: LFZ
Advisory panel: Microbiology
Date received: 1998-06-02
Decision date: 1998-11-25
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Columbia, MD, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.